Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
Cystic Fibrosis (CF) is an inherited disorder in which mucus-secreting glands in the lungs
produce considerable quantity of thick, sticky secretions that clog the airways, promote
bacterial growth and lead to chronic obstruction, inflammation and destruction of the
airways.
The purpose of this study is to collect data about the resolution of the chronic inflammatory
state in addition to assure the safety of the therapy in CF patients.